NSDHL Antikörper
Kurzübersicht für NSDHL Antikörper (ABIN6989853)
Target
Alle NSDHL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human NSDHL (NP_057006.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- NSDHL (NAD(P) Dependent Steroid Dehydrogenase-Like (NSDHL))
-
Andere Bezeichnung
- NSDHL
-
Hintergrund
-
Synonyms: NSDHL,H105E3,SDR31E1,XAP104
Background: The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene.
-
Gen-ID
- 50814
-
UniProt
- Q15738
Target
-